"Felt like an earthquake," Ahmedabad resident relives AI-171 crash experience
'When the crash happened, it felt like an earthquake. Immediately, we rushed to the site. 'After hearing the loud sound from the crash, the public gathered nearby,' he told ANI while recounting the moments of the crash.
Hariom Gandhi from the NDRF, who arrived at the AI-171 plane crash site, stated that six teams have been deployed and are actively carrying out operations on the ground.
'Our six teams are working on the ground. We cannot give any numbers until the site is completely cleared,' he said.
The Indian Medical Association (IMA ) Gujarat said that its Gujarat unit is working in close collaboration with CM of Gujarat Bhupendra Patel, Ministers Rushikesh Patel & Harsh Sanghavi, Health Secretary Dhananjay Dwivedi, senior IAS officers, government stakeholders, and Civil Hospital authorities.
'In a swift response to the tragic Ahmedabad Flight crash incident, IMA Gujarat is providing full on-ground support at the incident site & Civil Hospital, Ahmedabad. The IMA Gujarat team is working in close collaboration with CM of Gujarat Bhupendra Patel, Ministers Rushikesh Patel & Harsh Sanghavi, Health Secretary Dhananjay Dwivedi, senior IAS officers, government stakeholders, and Civil Hospital authorities as per their direct guidance to deliver the required medical aid & doctors' expertise,' IMA said in a statement.
A total of 241 people onboard the Boeing 787-8, Air India flight 171, including 12 crew members, have died in the deadly Ahmedabad plane crash, Air India confirmed post-midnight on Friday.
The flight, which was operating from Ahmedabad to London Gatwick on June 12, 2025, carried 169 Indian nationals, 53 British nationals, seven Portuguese nationals, and one Canadian national.
The passenger plane crashed near Sardar Vallabhbhai Patel International Airport in Gujarat's Ahmedabad into a resident doctors' hostel building shortly after take-off.
Miraculously, one person has survived the deadly crash, the airline authorities said, adding that the survivor was a British national of Indian origin.
The aircraft was piloted by Captain Sumeet Sabharwal, a Line Training Captain with 8,200 hours of flying experience, assisted by First Officer Clive Kundar, who had logged 1,100 flying hours.
According to Air Traffic Control (ATC), the aircraft departed from Ahmedabad at 1339 IST (0809 UTC) from runway 23. It made a Mayday call to ATC, but thereafter, the aircraft did not respond to the calls made by ATC.
Immediately after departing from Runway 23, the aircraft fell on the ground outside the airport perimeter. An official stated that heavy black smoke was emanating from the accident site.
The Tata Group has announced a compensation of Rs 1 crore for the families of each person who lost their lives in the crash. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
HCAH Appoints Dr. Gaurav Thukral and Ankit Goel as Co-Presidents
New Delhi: Out of hospital care provider company HCAH has appointed its Co-Founders, Dr. Gaurav Thukral and Ankit Goel , as Co-Presidents. The company states that the elevation marks aligning deep clinical expertise and entrepreneurial vision to make structured recovery the backbone of Indian healthcare . It is indicated that HCAH operates 7 centres with a total bed capacity of more than 400. The company is indicated to be backed by marquee investors including ABC Impact, Quadria Capital, and the Burman Family Office. Aditya Burman, Non-Executive Director, HCAH, said-'This leadership transition reflects our confidence in the direction HCAH is taking. Dr. Thukral and Ankit have led the company with a steady balance of clinical insight and operational strength. Their elevation comes at a time when recovery care is gaining long-overdue attention. HCAH is helping bring to India what has long been considered a luxury abroad—high-quality, structured rehabilitation—and making it part of our domestic reality. It's an important step as we continue to strengthen recovery as an essential part of the healthcare journey.' Ankit Goel, Co-Founder & President, HCAH, said- 'India's recovery challenge is enormous and growing. With 1.7 million strokes, 1.5 million joint replacements, and a rapidly expanding ageing population, the need for structured recovery is urgent. Yet, the current system remains fragmented, informal, and inaccessible to millions. HCAH is answering this call with clinical precision, operational scale, and technology-driven delivery models. We're not just raising standards. We're resetting them.'
Time of India
an hour ago
- Time of India
Gujarat becomes leading national centre for lung cancer treatment; 4,397 patients treated in 5 years
Gandhinagar: Inspired by Prime Minister Narendra Modi's vision of "Healthy India, Prosperous India," the Gujarat government, under the leadership of Chief Minister Bhupendra Patel, is advancing healthcare services across Gujarat, said a statement from the CMO. The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad has emerged as a crucial centre in this mission, providing advanced treatment to thousands of lung cancer patients over the past five years. Through focused initiatives and continuous innovation, Gujarat is paving the way for a healthier society, benefiting the nation as a whole. To position Gujarat as a global centre for medical excellence, the government of Gujarat, under the leadership of Chief Minister Bhupendra Patel, has earned the trust of patients from across India. This increasing confidence is reflected in the rising number of people seeking lung cancer treatment in Gujarat over the past five years. As per the statement, from 2020 to 2024, the Gujarat Cancer and Research Institute (GCRI) in Ahmedabad treated a total of 4,397 lung cancer patients (3,597 men, 799 women, and 1 child). The year-wise figures show a consistent increase: 700 patients in 2020, 813 in 2021, 865 in 2022, 933 in 2023, and a record 1,086 in 2024. The PMJAY-MA scheme has played a crucial role in making lung cancer treatment easily available in Gujarat. Over the past five years, thousands of patients have received advanced care through this initiative, providing significant relief to economically weaker sections. By reducing financial burdens and ensuring timely treatment, the scheme has helped save many lives. Notably, 1,426 lung cancer patients from other states have also sought treatment in Gujarat, drawn by the state's modern medical facilities. This growing trust reflects Gujarat's emergence as a reliable centre for cancer care, not only for the people of Gujarat but for patients from across India. Marking World Lung Cancer Day, the Gujarat Cancer and Research Institute (GCRI) has urged citizens to take proactive steps towards prevention, early detection, and timely treatment of lung cancer. The institute noted that more than 40 per cent of lung cancer cases in India are diagnosed at an advanced stage due to limited awareness, making treatment more complex and outcomes less favourable. GCRI has especially appealed to high-risk people, such as long-term smokers and those exposed to environmental pollutants, to undergo low-dose CT scans for early screening. Experts believe that timely diagnosis and swift medical intervention significantly improve survival and quality of life. GCRI Director Dr Shashank Pandya said, "Awareness is our greatest defence against lung cancer. Early screening, quitting tobacco, and recognising warning signs can save lives. At GCRI, we are committed to providing state-of-the-art diagnostics and holistic care for every patient." Driven by robust healthcare services and state-of-the-art infrastructure, Gujarat is becoming a preferred centre for medical tourism, not just for India but for the world. The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad offers cancer treatment on par with global standards, using advanced technologies like CyberKnife, True Beam, TomoTherapy, and Robotic Surgery, along with high-end diagnostics such as NGS, PET-CT, PSMA Scan, and 3 Tesla MRI.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Procter & Gamble Health rallies 10%, hits 4-year high on strong Q1 results
Procter & Gamble Health share price today Shares of Procter & Gamble Health hit a four-year high at ₹6,475, as they rallied 10 per cent on the BSE in Friday's intra-day trade in an otherwise weak market after the company reported strong earnings for the quarter ended June 2025 (Q1FY26). The stock price of the pharmaceutical company was quoting at its lowest level since April 2021. It had hit a record high of ₹7,499.95 on February 11, 2021. At 02:34 PM; Procter & Gamble Health was trading 7 per cent higher at ₹6,312.10, as compared to 0.40 per cent decline in the BSE Sensex. Q1 results - Procter & Gamble Health Procter & Gamble Health delivered a strong performance with sales of ₹333 crore, up 20 per cent against a year ago, owing to broad-based growth in domestic and exports business. Profit after tax (PAT) stood at ₹66 crore, against ₹17 crore a year ago, due to strong sales growth and one-time impact of impairment in the base period. Commenting on the performance, Milind Thatte, Managing Director, P&G Health India, said, "We are pleased with the continued momentum and strong start to the Financial Year 2025-26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities'. The company's strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results, Milind Thatte said. Opportunities, outlook The healthcare sector in India has undergone a significant transformation, fueled by substantial investments in infrastructural development. Since 2016, the Indian healthcare industry has witnessed a consistent growth trajectory. The consumer healthcare sector shows promising prospects for the future. The company is well-positioned to sustain and strengthen its position in the market. About Procter & Gamble Health Procter & Gamble Health Limited is one of India's largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Ambi Pur, Ariel, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide, Vicks, and Whisper. P&G operates in approximately 70 countries worldwide.
